Close
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c
  • SENSEX Apr 19 2024 12:00
    73,088.33 +599.34 ( +0.83%)
  • NIFTY Apr 19 2024 12:00
    22,147.00 +151.15 ( +0.69%)
  • SENSEX Apr 19 2024 12:00
    73,088.33 +599.34 ( +0.83%)
  • NIFTY Apr 19 2024 12:00
    22,147.00 +151.15 ( +0.69%)
  • Nasdaq Apr 20 2024 04:30
    15,282.01 -319.49 (-2.05%)
  • DJIA Apr 20 2024 04:30
    37,986.40 +211.02 ( +0.56%)
  • S&P 500 Apr 20 2024 04:30
    4,967.23 -43.89 (-0.88%)
  • Hang Seng Apr 19 2024 02:10
    16,224.14 -161.73 (-0.99%)
  • Crude Oil Apr 19 2024 11:29
    6,893.00 -3.00 (-0.04%)
  • Gold Apr 19 2024 11:29
    72,800.00 -6.00 (-0.01%)
  • Silver Apr 19 2024 11:29
    83,524.00 +17.00 ( +0.02%)
  • Copper Apr 19 2024 11:29
    845.40 +0.25 ( +0.03%)
  • Pound / Rupee Dec 23 2016 22:30
    104.11 +0.15 ( +0.15%)
  • Dollar / Rupee Dec 23 2016 22:30
    83.63 +0.04 ( +0.05%)
  • Euro / Rupee Dec 23 2016 22:30
    89.02 +0.23 ( +0.26%)
  • Yen / Rupee Dec 23 2016 22:30
    0.54 0.00 ( +0.05%)

BSE Code : | NSE Symbol : | ISIN:| SECTOR : |

NSE BSE
 

Volume

Prev. Close

Open Price

Bid Price (QTY)

Offer Price (QTY)

 

Today’s High/Low -

52 wk High/Low -

Key Stats

MARKET CAP (RS CR) 468.53
P/E 0
BOOK VALUE (RS) 213.8926174
DIV (%) 40
MARKET LOT 1
EPS (TTM) 0
PRICE/BOOK 2.94026043369181
DIV YIELD.(%) 0.64
FACE VALUE (RS) 10
DELIVERABLES (%)
4

News & Announcements

10-Feb-2024

Dai-ichi Karkaria consolidated net profit declines 87.91% in the December 2023 quarter

31-Jan-2024

Dai-ichi Karkaria revises board meeting date

27-Jan-2024

Dai-ichi Karkaria to announce Quarterly Result

26-Oct-2023

Dai-ichi Karkaria consolidated net profit rises 18.89% in the September 2023 quarter

31-Jan-2024

Dai-ichi Karkaria revises board meeting date

27-Jan-2024

Dai-ichi Karkaria to announce Quarterly Result

17-Oct-2023

Dai-ichi Karkaria to hold board meeting

12-Aug-2023

Dai-ichi Karkaria to conduct AGM

Corporate Actions

Bonus
Splits
Dividends
Rights
Capital Structure
Book Closure
Board Meeting
AGM
EGM
 

Financials

Income Statement

Standalone
Consolidated
 

Peers Comparsion

Select Company Name BSE Code NSE Symbol
Aarti Industries Ltd 524208 AARTIIND
Aarti Surfactants Ltd 543210 AARTISURF
Aarti Surfactants Ltd Partly Paidup 890180 AARTIPP
Absolute Aromatics Ltd 40209
Aditya Info-Soft Ltd 530693
Advance Petrochemicals Ltd 506947
Aether Industries Ltd 543534 AETHER
Alang Industrial Gases Ltd 531517
Alkali Metals Ltd 533029 ALKALI
Alkyl Amines Chemicals Ltd 506767 ALKYLAMINE
Allied Resins & Chemicals Ltd(merged) 524538 ALLIEDRES
Alufluoride Ltd 524634
Amal Ltd 506597
Ambani Organics Ltd 535097 AMBANIORG
Ambica Agarbathies Aroma & Industries Ltd 532335 AMBICAAGAR
Amex Carbonates & Chemicals Ltd 531321
Amines & Plasticizers Ltd 506248 AMNPLST
Aminex Chemicals Ltd (Wound-up) 524386
Amit Alcohol & Carbon Dioxide Ltd (Merged) 506904
Anan Drug & Chem Ltd 531999
Andhra Petrochemicals Ltd 500012 ANDHRAPET
Anjana Explosives Ltd 40329
Anupam Rasayan India Ltd 543275 ANURAS
Arabian Petroleum Ltd 77164 ARABIAN
Archean Chemical Industries Ltd 543657 ACI
Archit Organosys Ltd 524640
ARCL Organics Ltd 543993
Arvee Laboratories (India) Ltd 535050 ARVEE
Arvin Liquid Gases Ltd 523404
Asian Petroproducts & Exports Ltd 524434
Asiatic Oxygen Ltd 40030
Atul Ltd 500027 ATUL
Avikem Resins Ltd 523784
B L Industries (India) Ltd 530637
Balaji Amines Ltd 530999 BALAMINES
Barium Chemcials Ltd 506275
Baroda Carbons Ltd 523527
BASF India Ltd 500042 BASF
Benzo Petro International Ltd 524737
Benzo Petrochemicals Ltd (Wound Up) 524196
Bhagawati Gas Ltd 500051 BAGWATIGAS
Bhagawati Oxygen Ltd 509449
Bhatia Colour Chem Ltd 543497
Bhuruka Gases Ltd 509728
Bhuvan Tripura Industries Ltd 524725
Binaca Synthetic Resins Ltd 514344
Borax Morarji Ltd(Merged) 506315
Burmah Petro Products Ltd 40310
C J Gelatine Products Ltd 507515
Cabot India Ltd 506700 CABOTINDIA
Camlin Fine Sciences Ltd 532834 CAMLINFINE
Canvay Chemicals Ltd 531535
Caprolactam Chemicals Ltd 507486
Carbon & Chemicals India Ltd (Merged) 505813
Castrol India Ltd 500870 CASTROLIND
Cellulose Products of India Ltd 506345
Chembond Chemicals Ltd 530871 CHEMBOND
Chemcon Speciality Chemicals Ltd 543233 CHEMCON
Chemcrux Enterprises Ltd 540395
Chemfab Alkalis Ltd 541269 CHEMFAB
Chemiesynth (Vapi) Ltd 539230
Chemplast Sanmar Ltd 543336 CHEMPLASTS
Chimique Laboratories (India) Ltd 40300
Ciba India Ltd(merged) 532184 CIBASPEC
Cilson Organics Ltd 532147
Citric India Ltd 506370
Citurgia Biochemicals Ltd 506373 CITURGIBIO
Clariant (India) Ltd(merged) 500373 CLARIANT
Clarisis Organics Ltd 524806
Claro India Ltd 524366
Clean Science & Technology Ltd 543318 CLEAN
Cochin Minerals & Rutile Ltd 513353
Continental Petroleums Ltd 523232
Core Organics Ltd 524466
Crestchem Ltd 526269
DDev Plastiks Industries Ltd 543547
Deccan Petroleums Ltd 526375
Deepak Fertilizers & Petrochemicals Corp Ltd 500645 DEEPAKFERT
Deepak Nitrite Ltd 506401 DEEPAKNTR
Diamines & Chemicals Ltd 500120 DIAMINESQ
DIC India Ltd 500089 DICIND
Diviya Chemicals Ltd 506810
DMCC Speciality Chemicals Ltd 506405 DMCC
Doctors Biotech India Ltd 512079
Dujodwala Paper Chemicals Ltd 524276
Eiko Lifesciences Ltd 540204
Eiko Lifesciences Ltd Partly Paidup 890189
Elantas Beck India Ltd 500123 DRBECK
Ellenbarrie Industrial Gases Ltd 590087
Emmessar Biotech & Nutrition Ltd 524768
EPIC Enzymes Pharma & Industrial Chemicals Ltd 524374
Fairchem Organics Ltd 543252 FAIRCHEMOR
Ficom Organics Ltd(merged) 506443 FICOMORGAN
Fine Organic Industries Ltd 541557 FINEORG
Fineotex Chemical Ltd 533333 FCL
Foseco India Ltd 500150 FOSECOIND
Futuristic Offshore Services and Chemical Ltd 500154 GANESHANHY
Gagan Gases Ltd 524624
Galaxy Oleo-Chem (India) Ltd 40207
Galaxy Surfactants Ltd 540935 GALAXYSURF
GBL Industries Ltd 539009
GHCL Ltd 500171 GHCL
Glory Chemicals Ltd 531532
GOCL Corporation Ltd 506480 GOCLCORP
Godrej Industries Ltd 500164 GODREJIND
Goiex Michio Sudo Ltd 507978
GOM Industries Ltd 523802
Goodearth Industries Ltd 526929
Goodearth Organic (India) Ltd [Wound-up] 524300
Govind Poy Oxygen Ltd 509586
GP Petroleums Ltd 532543 GULFPETRO
Grauer & Weil (India) Ltd 505710 GRAUWEIL
Gresoil (India) Ltd 530483
Gujarat Carbon & Industries Ltd 506457
Gujarat Fluorochemicals Ltd 542812 FLUOROCHEM
Gujarat Indo-Lube Ltd 523552
Gujarat Narmada Valley Fertilizers & Chemicals Ltd 500670 GNFC
Gujarat Oiland Industries Ltd (Wound Up) 507866
Gujarat Organics Ltd 501368
Gujarat Speciality Lubes Ltd 523880
Gulf Oil India Ltd - Merged 511026 GULFOIL
Gulf Oil Lubricants India Ltd 538567 GULFOILLUB
Gulshan Sugars & Chemicals Ltd(merged) 524184
Haryana Leather Chemicals Ltd 524080
Hemo Organic Ltd 524590
Hico Products Ltd 506461
Hi-Green Carbon Ltd 91663 HIGREEN
Hilltone Industrial Gases Ltd 40441
Himadri Speciality Chemical Ltd 500184 HSCL
Hindcon Chemicals Ltd 535053 HINDCON
Hindustan Industrial Chemicals Ltd 524679 HINDINDCHM
Hindustan Organic Chemicals Ltd 500449 HOCL
Hindustan Oxygen Gas Ltd 509660
HP Adhesives Ltd 543433 HPAL
Hubergroup India Pvt Ltd 523886 MICRO
I G Petrochemicals Ltd 500199 IGPL
IBP Co. Ltd(merged) 500198 IBP
Iccon Oil & Specialities Ltd 523766
India Carbon Ltd 40012
India Gelatine & Chemicals Ltd 531253
Indian Electro Chemicals Ltd 506490
Indo Amines Ltd 524648 INDOAMIN
Indo Borax & Chemicals Ltd 524342 INDOBORAX
Indo Gulf Industries Ltd 506945
Indo Vanillon Chemicals Ltd 531267
Indu Nissan Oxo Chemicals Industries Ltd 500208 INDUNISSAN
Inox Air Products Pvt Ltd 526534 INDOXYGEN
Insilco Ltd 500211 INSILCO
Iota Chemiculture Ltd(Liquidated) 524630
IVP Ltd 507580 IVP
J F Laboratories Ltd 523804 JFLABS
J.G.Chemicals Ltd 544138 JGCHEM
J.R. Organics Ltd 506650
Jay Agrochem Ltd (Wound Up) 513504
Jayant Agro Organics Ltd 524330 JAYAGROGN
Jocil Ltd 500561 JOCIL
Jubilant Industries Ltd 533320 JUBLINDS
Jubilant Ingrevia Ltd 543271 JUBLINGREA
Jyoti Resins and Adhesives Ltd 514448
K P Gelatines & Chemicals India Ltd (Wound-up) 524741
Kamar Chemicals & Industries Ltd 531001
Kanchi Karpooram Ltd 538896
Kanoria Chemicals & Industries Ltd 506525 KANORICHEM
Kanva Hydro Chem Ltd 524685
Karnataka Chemical Industries Corp Ltd 530105
Karnav Leather Chemicals Ltd 524432
Keltech Energies Ltd 506528
Kesar Petroproducts Ltd 524174
Kilburn Chemicals Ltd 524699
Kings India Chemicals Corporation Ltd 524214
Kothari Polymers Ltd 40360
Krishna Plastochem Ltd (Wound Up) 524254
Laxmi Organic Industries Ltd 543277 LXCHEM
Lime Chemicals Ltd 507759
Linde India Ltd 523457 LINDEINDIA
Link Pharma Chem Ltd 524748
Lords Chemicals Ltd 530039
M.P. Carbide & Chemicals Ltd 506925
Madras Petrochem Ltd 500261
Maha Chemicals Ltd (Wound-up) 524556
Maharashtra Explosives Ltd (Wound-up) 506871
Maharashtra Polybutenes Ltd 524232
Mangalam Organics Ltd 514418 MANORG
Mark Omega Organic Industries Ltd 524681
Maruti Industrial Carbohydrates Ltd 524814
Maruti Organics Ltd 524402 MARUTIORNG
Master Chemicals Ltd 506867
Mehta Rubber Chemcials Ltd 526536
Mehta Sulfites (India) Ltd 530029
mk Aromatics Ltd 531011
Motorol (I) Ltd 508965 MOTOROL
Motorol Enterprises Ltd 523049 RINKIPETRO
Motorol Speciality Oils Ltd 506954
MTZ Industries Ltd 500275 METAZINC
Murablack India Ltd 523578 MURABLACK
Nacro Chemicals Ltd 524350
Nariman Point Chemical Industries Ltd 524224
Narmada Gelatines Ltd 526739 SHAWGELTIN
National Oxygen Ltd 507813 NOL
Navin Fluorine International Ltd 532504 NAVINFLUOR
Neogen Chemicals Ltd 542665 NEOGEN
Newton Engineering & Chemicals Ltd 524474
Nikhil Adhesives Ltd 526159
Niraj Petrochemicals Ltd 500454 NIRAJPETRO
Nitta Gelatin India Ltd 506532 KERALACHEM
NLC Nalco India Ltd 524101 NALCOCHEM
Noble Explochem Ltd 506991
NOCIL Ltd 500730 NOCIL
Nouryon Chemical India Pvt Ltd 500082 CENTAKCHEM
Nova Chemie (India) Ltd 40188
Ojas Technochem Products Ltd(wound-up) 526427
Omkar Speciality Chemicals Ltd 533317 OMKARCHEM
Organic Coatings Ltd 531157
Orient Organics Ltd 524766
Oriental Aromatics Ltd 500078 OAL
Oriental Carbon & Chemicals Ltd 506579 OCCL
Orissaa Organics Ltd 524392
Oswali Chemicals Ltd 506916
Padmanabh Industries Ltd 526905
Paintex Chemicals (Bombay) Ltd 524178
Paragon Fine and Speciality Chemical Ltd 91901 PARAGON
Paschim Petrochem Ltd 531005
Paushak Ltd 532742
PCBL Ltd 506590 PCBL
Pentasia Chemicals Ltd (Merged) 507739
Pidilite Industries Ltd 500331 PIDILITIND
Pinky Chemicals Ltd 524671
Plastiblends India Ltd 523648 PLASTIBLEN
Platinum Industries Ltd 544134 PLATIND
Polyolefins Industries Ltd (Merged) 506610
Premier Explosives Ltd 526247 PREMEXPLN
Privi Speciality Chemicals Ltd 530117 PRIVISCL
Protchem Industries (India) Ltd 524117
Rain Calcining Ltd(merged) 532153 RAINCALCIN
Rathi India Ltd 506959
Refnol Resins & Chemicals Ltd(Merged) 530815
Rencal Chemicals (India) Ltd 524510
Resonance Specialities Ltd 524218
Revati Organics Ltd 524504
Rhodia Specialty Chemicals India Ltd(Merged) 506230 ALBRMORARJ
Rite Zone Chemcon India Ltd 535489 RITEZONE
Ritesh International Ltd 519097
Rock Hard Petro Chemical Industries Ltd 524194
Rossari Biotech Ltd 543213 ROSSARI
Rukmani Metals & Gaseous Ltd 40695
S H Kelkar & Company Ltd 539450 SHK
S K R Chemicals Ltd 530371
Sadhana Nitro Chem Ltd 506642 SADHNANIQ
Salvigor Laboratories Ltd (Merged) 524268
Sanderson Industries Ltd 507728 SANDERIND
Sanginita Chemicals Ltd 538408 SANGINITA
Sarang Chemicals Ltd 532031
Searsole Chemicals Ltd (Wound-up) 506644
Seya Industries Ltd 524324 SEYAIND
Shaper Chemicals Ltd (Wound-up) 524566
Shayona Petrochem Ltd 531538
Shentracon Chemicals Ltd 530757
Shree Benzophen Industries Ltd 531389
Shree Neelachal Laboratories Ltd 531487
Shri Ambuja Petro Chemicals Ltd 506742
Shri Aster Silicates Ltd 533219 SHRIASTER
Shri Nicosect Ltd 526437
SI Group - India Ltd 506460 SIGROUPIND
SMZS Chemicals Ltd(wound-up) 524160 SMZSCHEM
Solar Industries India Ltd 532725 SOLARINDS
Sonal Sil Chem Ltd 524673
Southern Gas Ltd 509910
Speciality Petrolubes Ltd 523525
Sree Rayalaseema Hi-Strength Hypo Ltd 532842 SRHHYPOLTD
Sree Rayalaseema Petrochemicals Ltd (Merged) 524618
Sreechem Resins Ltd 514248
SRF Ltd 503806 SRF
SRHHL Industries Ltd (Merged) 524410 SRHHLINDST
Sterling Biotech Ltd 512299 STERLINBIO
Sudev Chemicals Ltd 40666
Sun Star Chemicals Ltd 524536 SUNSTRCHEM
Sunshield Chemicals Ltd 530845
Sunstar Lubricants Ltd 524452 SUNSTARLUB
Superior Air Products Ltd (Merged) 526469
Swarnajyothi Agrotech & Power Ltd 590090
Tamil Nadu Industrial Explosives Ltd 524028
Tamil Nadu Petro Products Ltd 500777 TNPETRO
Tanfac Industries Ltd 506854 TANFACIND
Tata Chemicals Ltd 500770 TATACHEM
Tatva Chintan Pharma Chem Ltd 543321 TATVA
TECIL Chemical & Hydro Power Ltd 506680 TECILCHEM
Tetrahedron Ltd 40308
Thirani Chemicals Ltd (Merged) 524125
Thirumalai Chemicals Ltd 500412 TIRUMALCHM
Tide Water Oil Co (I) Ltd 590005 TIDEWATER
Tirupati Inks Ltd 533258
Transpek Industry Ltd 506687 TRANSPEK
Tria Fine Chem Ltd 524721
Tribology India Ltd 40171
Trigon Zinco Ltd 530287
Tulasee Bio-Ethanol Ltd 524514
U P Lime Chem Ltd 524677
Unique Oils India Ltd 523250
Urvi Chemicals & Allied Industries Ltd 501371
Vadilal Chemicals Ltd 40485
Vadivarhe Speciality Chemicals Ltd 538429 VSCL
Valiant Organics Ltd 540145 VALIANTORG
VBC Industries Ltd 524310
Vibros Organics Ltd 530487
Vijayshree Chemicals (India) Ltd 524312
Vikas Wsp Ltd 519307 VIKASWSP
Vinati Organics Ltd 524200 VINATIORGA
Vishnu Chemicals Ltd 516072 VISHNU
Vision Organics Ltd 532383 VISIONLTD
Vital Chemtech Ltd 535490 VITAL
Yasho Industries Ltd 541167 YASHO
Yug Decor Ltd 540550

Share Holding

Category No. of shares Percentage
Total Foreign 140292 1.88
Total Institutions 0 0.00
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 299072 4.01
Total Promoters 4759822 63.88
Total Public & others 2252043 30.22
Total 7451229 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

About Dai-ichi Karkaria Ltd

Dai-Ichi Karkaria Limited (DIK) was incorporated on 13 May 1960. The Company is engaged in manufacturing of specialty chemicals. The manufacturing activities of the Company are carried out from plants located at Dahej (Gujarat) and Kurkumbh (Maharashtra). The Company manufactures speciality chemicals has a tie-up with Matsumoto to manufacture spin finishes, which are used for imparting lubrication and anti-static properties to textile filaments and yarns. It is now expanding its production capacity from 750 tpa to 3000 tpa. DIK had set up a unit to manufacture certain bulk drugs omeprazole, menadione and calcium pentothenate, the last two will be manufactured in India for the first time. DIK is also setting up a unit to manufacture 600 tpa of polyacrylamide-based flocculents which are used for solid-liquid separation. The expansion cum Diversification plan for High Molecular Weight Flocculants Project at Kurkumbh has been successfully completed. Company had joint venture with project consultant for effluent treatment plants for increasing business. Company Bulk Drugs & Fine Chemical Projects for patented molecule processes were developed and were scaled up to commercial level by March-99. Company plans to start development of three new products in the pilot facility which is being upgraded presently to meet strict cGMP condition. Company also negotiating with foreign customer for product specific tie-ups in future. Company Spin fishes continue to do well & POY DTY finish has been accepted in the market & company hopes to get orders from leading synthetic fibre manufacturers. During the year 1999-2000, the company's successfully introduced eight new products in therapeutic areas of cardiovascular, antihistaminics, analgesics, anxiolytic, antidepressant and anticonsulgants. The Company introduced Emulsifier for Aqua flowables in pesticide formulations during 2001-02. The Pharmaceuticals business was transferred to Inogent Laboratories Pvt. Ltd., a Joint Venture with GVK Bio and Dai-ichi Karkaria Ltd., in October 2005. During the year 2010-11, the Company had formed a joint venture with CTI Chemicals Asia Pacific Pte. Ltd. (Subsidiary of Champion Technologies Inc.) and its wholly owned subsidiary Basic Oil Treating (India) Ltd. Through the formation of a Joint venture, the shareholding of Champion Dai-ichi Technologies India Ltd. was held by the Company and CTI Chemicals Asia Pacific Pte. Ltd. in the ratio of 50:50. Accordingly Champion Dai-ichi Technologies India Ltd. ceased to be a subsidiary of the Company w.e.f. 7th September, 2010.

Dai-ichi Karkaria Ltd Chairman Speech

Dai-ichi Karkaria Ltd Company History

Dai-Ichi Karkaria Limited (DIK) was incorporated on 13 May 1960. The Company is engaged in manufacturing of specialty chemicals. The manufacturing activities of the Company are carried out from plants located at Dahej (Gujarat) and Kurkumbh (Maharashtra). The Company manufactures speciality chemicals has a tie-up with Matsumoto to manufacture spin finishes, which are used for imparting lubrication and anti-static properties to textile filaments and yarns. It is now expanding its production capacity from 750 tpa to 3000 tpa. DIK had set up a unit to manufacture certain bulk drugs omeprazole, menadione and calcium pentothenate, the last two will be manufactured in India for the first time. DIK is also setting up a unit to manufacture 600 tpa of polyacrylamide-based flocculents which are used for solid-liquid separation. The expansion cum Diversification plan for High Molecular Weight Flocculants Project at Kurkumbh has been successfully completed. Company had joint venture with project consultant for effluent treatment plants for increasing business. Company Bulk Drugs & Fine Chemical Projects for patented molecule processes were developed and were scaled up to commercial level by March-99. Company plans to start development of three new products in the pilot facility which is being upgraded presently to meet strict cGMP condition. Company also negotiating with foreign customer for product specific tie-ups in future. Company Spin fishes continue to do well & POY DTY finish has been accepted in the market & company hopes to get orders from leading synthetic fibre manufacturers. During the year 1999-2000, the company's successfully introduced eight new products in therapeutic areas of cardiovascular, antihistaminics, analgesics, anxiolytic, antidepressant and anticonsulgants. The Company introduced Emulsifier for Aqua flowables in pesticide formulations during 2001-02. The Pharmaceuticals business was transferred to Inogent Laboratories Pvt. Ltd., a Joint Venture with GVK Bio and Dai-ichi Karkaria Ltd., in October 2005. During the year 2010-11, the Company had formed a joint venture with CTI Chemicals Asia Pacific Pte. Ltd. (Subsidiary of Champion Technologies Inc.) and its wholly owned subsidiary Basic Oil Treating (India) Ltd. Through the formation of a Joint venture, the shareholding of Champion Dai-ichi Technologies India Ltd. was held by the Company and CTI Chemicals Asia Pacific Pte. Ltd. in the ratio of 50:50. Accordingly Champion Dai-ichi Technologies India Ltd. ceased to be a subsidiary of the Company w.e.f. 7th September, 2010.

Dai-ichi Karkaria Ltd Directors Reports

Dear Members,

Your Directors have pleasure in presenting the Sixty-third Annual Report together with the audited accounts for the year ended March 31, 2023.

FINANCIAL RESULTS (STANDALONE):

Particulars

As on 31st March, 2023 As on 31st March, 2022
Revenue from operations 18,394 12,184
Other Income 644 608
Total Income 19,038 12,792

Profit/ (Loss) before Exceptional item, Depreciation/ Amortization, Interest and Tax

2,233 (1,229)
Profit/ (Loss) after exceptional item after tax 1,847 (1,658)
Earnings per equity share: Basic and Diluted (` 10/- each) 24.79 (22.25)
Book Value of shares (`) 198.53 173.73

DIVIDEND:

The Directors are pleased to recommend a dividend of ` 4 per equity share of ` 10/- each for the year ended March 31, 2023, subject to the approval of Members at the ensuing Annual General Meeting. The dividend payout will aggregate to ` 298.05 lakhs. In view of the changes made under the Income-tax Act, 1961, by the Finance Act, 2020, dividends paid or distributed by the Company shall be taxable in the hands of the Shareholders. The Company shall, accordingly, make the payment of the Dividend after deduction of tax at source, as applicable.

MANAGEMENT DISCUSSION AND ANALYSIS REPORT:

The Indian economy having recovered in the 2021-22, after the pandemic induced slowdown, continues to be resilient, in spite of the impact of the present geopolitical situation.

Though 2022 was a year of worldwide uncertainty with global events like the Ukraine war and significant cost inflation disrupting supply chains and lowering consumer demand, the Indian Economy has faced the challenges well. Although many companies faced contracting gross margins due to soaring raw material costs and increasing operating costs due to higher freight, the chemical industry is once again regaining lost ground.

In the short-term elevated prices of energy and other commodities, and other supply-side disruptions have posed challenges for growth prospects in some sectors.

INDUSTRY STRUCTURE AND DEVELOPMENT, OPPORTUNITIES AND THREATS, RISK AND CONCERNS:

The Indian chemical industry is predicted to become a US dollar 300 billion industry by 2025 and to potentially become a $1 trillion industry in the next decade.

As the country embarks on massive Infrastructure and capacity additions there is a tremendous opportunity for growth in spite of the challenges and concerns.

Specialty chemicals constitute 22% of the total chemical and petrol chemical market in India. The industry grew from US dollars 18 billion in 2014 to US dollars 32 billion in 2019 and would be worth 64 billion by 2025.

However, India's share in the global specialty chemical market remains at around 4%.

The year 2022-23 would mark close to full recovery for the chemical industry with strong demand for most specialty chemicals and enhanced capital expenditure with growth in end markets.

India's specialty chemicals segment may have had a new opportunity in the wake of the pandemic. Consumers across the globe are diversifying away from China. While China itself had cracked down on many segments to cut pollution, resulting in many Indian companies picking up some market share as well as improving export prospects.

China has now made a very quick recovery and an aggressive comeback.

Customer expectations and behaviours have changed dramatically in the last 2/3 years and the chemical business will have to adapt to these changes.

COMPANY'S PERFORMANCE:

With our newly expanded plant in place, our new strategy, focuses on growing sustainable value by leveraging the company's existing strengths in leadership, technology, and market reputation.

We will focus on high value niches of the Oilfield sector, Agro and Crop care, Paints and Coatings, and Personal and Homecare. We are confident that over the next couple of years, we should be able to unlock the true potential of the company by focusing on our core businesses that have lasting advantages, resulting in strong, profitable growth.

Dai-ichi Karkaria Limited continues with its leading positions or advantages, as a preferred supplier to several long time customers. Though our focus will continue to be on the oilfield sector, we will also work towards leading positions in the Agro-industry, and the Paint industries.

In all three sectors, we have positioned ourselves with partners or strategic customers to gain leadership positions and enhance our product portfolio through customized development.

The Company continues to develop high performance products, providing customisable solutions to its customers' needs.

VERTICAL-WISE PERFORMANCE: AGRO:

In the Agro vertical the sales achieved in the year were slightly higher, having grown by 6% over the sales of the previous year. This year we started the export business for Agro emulsifiers by servicing a newly developed order for a speciality emulsifier with a leading manufacturer of Pesticides.

A new grade of dispersing agent was also introduced this year and bulk orders have been received from a key local customer. The industry trend is to slowly move from EC formulations to SC formulations as far as possible, due to environmental concerns, as EC formulations need aromatic and aliphatic solvents, while water is the main diluent in SC formulations. Similarly, WP formulations may move towards WDG type since inhaling dust during manufacture and usage of WP formulations is a health hazard.

Approval for our newly developed import-substitute specialty surfactants for SC formulations have been obtained from key customers.

Agro will continue to remain one of the focus segments for the company.

HOME AND PERSONAL CARE:

Sales in this vertical have grown by 10% in value terms over the previous year. Sales of the emulsifier for Oleoresin exports were maintained, although this year due to a recessionary effect in the US and EU, the exports of Oleoresins faced a slowdown. The sales are now stabilizing, and we expect a steady growth in FY 2023-24.

ENERGY AND OIL SECTOR:

Though India continues to be the fastest-growing major economy, and a bright spot in the world stricken by war and the after-effects of the pandemic, its share in the global oil demand is only 5% and is expected to rise to 11% in the forthcoming future. As the domestic exploration and production increases, the new opportunities to supply production chemicals also grows. For most of 2022-23 the company has been functioning with a limited capacity for its Oilfield chemicals. The new plant was setup by Mid-December, and has been operative during the last quarter.

The sales to the Oilfield sector (including our sales to our JV CXDI) have registered a growth close to 110% in FY 2023 over the previous year.

New grades of PPDs were introduced during the year, both for upstream and downstream applications, and exports of these have started to our key customers. New grades of PPDs were also developed and supplied to our JV partner.

The Company generally has good order book of Oilfield products in last two quarters of the financial year.

PAINTS AND COATINGS:

In this segment the sales have registered a growth of 18% in FY 2023 over the previous year. Sales to a leading emulsion making unit have grown by more than 50% in volumes.

Sales of an import-substitute EO-PO based fluid witnessed a growth in sales of more than 100% in both volume and value during the year over the previous year.

Pigment exports which had a slowdown during the first three quarters picked up in the fourth quarter and sales of the pigment dispersing agents through our distributors have now stabilised.

New customers have been added in this segment and sales have started, and should see a growth during the new financial year. Overall we are cautiously optimistic about the year ahead, in spite of the worldwide slowdown in many areas.

KEY FINANCIAL RATIOS:

Details of significant changes in key financial ratios alongwith explanation thereof are provided in Note 45 of Notes to financial statements as per Schedule III.

DETAILS OF INTERNAL FINANCIAL CONTROLS:

The Board of Directors have laid down Internal Financial Controls ("IFC") within the meaning of the explanation to Section 134(5)(e) of the Companies Act, 2013. The Board believes the Company has sound IFC commensurate with the nature and size of its business. Business is however dynamic. The Board is seized of the fact that IFC are not static and are in fact a fluid set of tools which evolve over time as the business, technology and fraud environment changes in response to competition, industry practices, legislation, regulation and current economic conditions. There will therefore be gaps in the IFC as Business evolves. The Company has a process in place to continuously identify such gaps and implement newer and or improved controls wherever the effect of such gaps would have a material effect on the Company's operations.

MATERIAL DEVELOPMENTS ON HUMAN RESOURCES INCLUDING NUMBER OF PEOPLE EMPLOYED:

All manpower requirements are assessed and filled in a timely manner. The Company has a sound knowledge pool of experienced employees, which helps it to maintain consistency in performance across all disciplines. It has built a team of dedicated employees, who work with commitment and a sense of belonging towards the growth of the Company.

Following areas are given special attention to enhance performance of the employees.

Identification of training & development needs and upgrade job specific skills.

Compensation, recognition & rewards.

Career growth plan through annual assessment.

Supporting employment related legislative compliance.

Promoting excellence in human resource management.

The promotion of an atmosphere of mutual respect, fairness and concern.

Company has extended its facility for Apprentice Scheme, to needy and economical weak youths for pursuing special industrial training.

EMPLOYEE ENGAGEMENT:

Implemented Employee uniform with ID card for Identification for all employees.

COVID-19 Insurance Policy was renewed.

GMC Group Insurance Policy was introduced.

INDUSTRIAL RELATIONS:

The Industrial relations at Dahej and Kurkumbh Plants remained cordial and amicable during the financial year 2022-23.

NUMBER OF PEOPLE EMPLOYED:

As on March 31, 2023, the total numbers of employees on the payrolls of the company are 182.

CHANGES IN CAPITAL STRUCTURE:

During the financial year under review there was no change in the authorized and paid-up share capital of the Company.

JOINT VENTURE / ASSOCIATE/ SUBSIDIARY COMPANIES:

Dai-ichi Karkaria Limited has a Joint venture with CTI Chemicals Asia Pacific Pte. Ltd., in ChampionX Dai-ichi India Private Limited in the ratio of 50:50.

The Company has a Subsidiary, Dai-ichi Goseichemicals (India) Limited. The Annual accounts of the Subsidiary Company are placed on the website of the Company and will be provided to the members on request.

As per the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Companies Act, 2013 and applicable Accounting Standards, the Consolidated Financial Statements of the Company with its Joint Venture Company, ChampionX Dai-ichi India Private Limited and Subsidiary Company, Dai-ichi Goseichemicals (India) Limited, duly audited by the Statutory Auditors are attached to the financials.

Statements containing salient features of the financial statement of subsidiary/ associate company/ joint venture are also attached to the financials.

DIRECTORS AND KMP:

The Members of the Company by special resolutions passed through postal ballot dated March 30, 2023 had approved the change in designation of Mrs. Shernaz Vakil from Chairperson and Managing Director to Chairperson and Whole-time Director of the Company effective April 1, 2023 upto her remaining tenure i.e. till March 31, 2025 and change in designation of Ms. Meher Vakil from Whole-time Director to Managing Director of the Company for a period from April 1, 2023 to March 31, 2026 and revision in terms of her remuneration.

Mrs. Shernaz Vakil retires by rotation, in pursuance of the provisions of the Companies Act, 2013 and Articles of Association of the Company and being eligible offered herself for re-appointment. The Board of Directors recommends her re-appointment. The information required to be furnished under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 & Secretarial Standards are provided in the Notice of the 63rd Annual General Meeting.

The Members of the Company had appointed Mr. Kavas Patel and Mr. Keki Elavia as Independent Directors to hold office upto the conclusion of this 63rd Annual General Meeting, not liable to retire by rotation and appointed Mr. Ashok Hiremath as Independent Director of the Company to hold office upto the conclusion of 65th Annual General Meeting, not liable to retire by rotation. All Independent Directors have given declarations that they continue to meet the criteria of independence as laid down under the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

In the opinion of the Board, all Independent Directors possess requisite qualifications, experience, expertise and hold high standards of integrity for the purpose of Rule 8(5)(iiia) of the Companies (Accounts) Rules, 2014. List of key skills, expertise and core competencies of the Board, including the Independent Directors, is provided as part of the Corporate Governance Report. Pursuant to the provisions of Regulation 34(3) read with Schedule V to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has obtained a Certificate from M/s. Vinod Kothari & Company, Practicing Company Secretaries certifying that none of the Directors of the Company has been debarred or disqualified from being appointed or continuing as Directors of companies by the Securities and Exchange Board of India (SEBI) or by the Ministry of Corporate Affairs (MCA) or by any such statutory authority. The said Certificate is annexed to the Corporate Governance Report of the Company for the Financial Year 2022-23.

Pursuant to the provisions of Section 203 of the Act, the Key Managerial Personnel of the Company as on March 31, 2023 are Mrs. Shernaz Vakil, Chairperson & Managing Director, Ms. Meher Vakil, Whole-time Director, Mr. Farokh Gandhi, Chief Financial Officer and Mr. Ankit Shah, Company Secretary.

DIRECTORS' RESPONSIBILITY STATEMENT:

To the best of their knowledge and belief and according to the information and explanations obtained by them, your Directors make the following statements in terms of Section 134(5) of the Companies Act, 2013:

In the preparation of the annual accounts, for the financial year ended March 31, 2023, the applicable accounting standards had been followed along with proper explanation relating to material departures;

The Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year March 31, 2023 and of the profit and loss of the company for that period;

Proper and sufficient care has been taken for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

The annual accounts have been prepared on a ‘going concern' basis;

Proper internal financial controls laid down by the Directors were followed by the Company and that such internal financial controls are adequate and operating effectively;

Proper systems to ensure compliance with the provisions of all applicable laws were in place and that such systems are adequate and operating effectively.

BOARD EVALUATION:

Pursuant to the provisions of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has carried out an annual performance evaluation of its own performance, individual directors and its committees. In a separate meeting of independent directors, performance of non-independent directors, the Board as a whole and the Chairperson & Whole-time Director and Managing Director of the Company were evaluated, taking into account the views of executive directors and non-executive directors.

The manner in which the evaluation has been carried out has been explained in the Corporate Governance Report forming part of the Annual Report.

NUMBER OF MEETINGS OF THE BOARD AND COMMITTEES OF THE BOARD:

Details regarding Board / Committees, its composition, number of meetings held, terms of reference, policies adopted are provided under the Corporate Governance Report forming part of the Annual Report.

CORPORATE SOCIAL RESPONSIBILITY (CSR):

The Company has constituted a Corporate Social Responsibility (CSR) Committee pursuant to Section 135 of the Companies Act, 2013. Details regarding CSR Committee, its composition, terms of reference, policy adopted are provided under the Corporate Governance Report forming part of the Annual Report.

In view of average net losses for the last three financial years as computed under Section 198 of the Companies Act, 2013, the Company was not mandated to undertake Corporate Social Responsibility activities during the financial year 2022-23 and the Company ceases to meet the criteria of Section 135(1) of the Companies Act, 2013 for the immediately preceding financial year, accordingly the provisions for calling CSR Committee meeting, spending and reporting on Corporate Social Responsibility activities are not applicable for FY 2022-23.

PARTICULARS OF EMPLOYEES AND REMUNERATION:

The remuneration paid to Directors and Key Managerial Personnel of the Company during the Financial Year 2022-23 was in conformity with the Nomination and Remuneration Policy of the Company.

The disclosures pertaining to remuneration and other details as required under Section 197(12) of the Act read with Rule 5(1) (2) and (3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 as amended and forming part of the Directors' Report for the year ended March 31, 2023 is annexed herewith as "Annexure – I" to this Report.

AUDITORS AND AUDIT REPORTS:

STATUTORY AUDITORS AND THEIR REPORT:

At the 62nd Annual General Meeting of the shareholders of the Company held on June 29, 2022, B S R & Co. LLP were appointed as the Statutory Auditors of the Company to hold office from the conclusion of 62nd Annual General Meeting upto the conclusion of 67th Annual General Meeting of the Company. Details of the remuneration paid to B S R & Co. LLP, Chartered Accountants, Statutory Auditors, during financial year 2022-23 are disclosed in the Corporate Governance Report, which forms part of the Annual Report.

During the year under review, the Statutory Auditors have not reported any instances of frauds committed in the Company by its Officers or Employees, to the Audit Committee or Board under Section 143(12) of the Act. The Auditors' Report on the Financial Statements, both Standalone and Consolidated for the financial year ended March 31, 2023 does not contain any qualifications, reservations or adverse remarks and forms part of Annual Report.

The Notes to the Financial Statements (Standalone and Consolidated) are self-explanatory and do not call for any further comments.

INTERNAL AUDITORS:

Due to change in re-organization structure of Mazars consulting activities in India, the Internal Audit assignment of the Company which was carried by "Mazars Business Advisors Private Limited" was serviced by the partnership firm "Mazars" for financial year 2022-23.

Mazars, are the Internal Auditors of the Company for the FY 2022-23. The Management regularly reviews the findings of the Internal Auditors and effective steps to implement any suggestions/observations of the Internal Auditors are taken and monitored regularly. In addition, the Audit Committee of the Board regularly addresses significant issues raised by the Internal Auditors.

SECRETARIAL AUDITORS AND THEIR REPORT:

Pursuant to the provisions of Section 204 of the Companies Act, 2013 and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Company had appointed M/s. Vinod Kothari & Company, a firm of Practicing Company Secretaries to undertake the Secretarial Audit of the Company for the F.Y. 2022-23 and the Secretarial Audit Report is annexed herewith as ‘Annexure II'. There is no reservation, qualification or adverse remark in their Report.

Further, in terms of the provisions of the Circular No. CIR/ CFD/CMD1/27/2019 dated February 8, 2019 issued by Securities and Exchange Board of India, the Company has obtained the Annual Secretarial Compliance Report from M/s. Vinod Kothari & Company, for the financial year ended March 31, 2023, confirming compliance of the applicable SEBI Regulations and circulars/ guidelines issued thereunder, by the Company.

COST AUDITORS:

Pursuant to Section 148 of the Companies Act, 2013 read with the Companies (Audit and Auditors) Rules, 2014 and the Companies (Cost Records and Audit) Rules, 2014, the cost records are required to be maintained by your Company and the same are required to be audited. The Company, accordingly, maintains the required cost accounts and records. The Company had appointed Mr. Sudhir Govind Jog, Cost Accountants, as the Cost Auditor for the financial year ended March 31, 2023, and the Cost Audit Report when submitted by them, will be duly filed with Ministry of Corporate Affairs.

As per Section 148 of the Companies Act, 2013 read with the Companies (Cost Records and Audits) Rules, 2014, the Board of Directors on recommendation of the Audit Committee, at its meeting held on May 30, 2023, approved the appointment of M/s. Diwanji & Associates, Cost Accountants, Firm's Registration No. 100227 as the Cost Auditor to conduct audit of the cost records of the Company for the financial year ending March 31, 2024. The Company has received written consent and certificate of eligibility from M/s. Diwanji & Associates, Cost Accountants, in accordance with Section 148 read with Section 141 and other applicable provisions of the Act and Rules made thereunder.

In terms of the provisions of Section 148(3) of the Companies Act, 2013 read with the Companies (Audit and Auditors) Rules, 2014, as amended, the remuneration payable to the Cost Auditor has to be ratified by the Members of the Company. Accordingly, the matter relating to ratification of the remuneration payable to M/s. Diwanji & Associates as the Cost Auditor of the Company for the financial year ending March 31, 2024 is being placed at the 63rd AGM.

HEALTH, SAFETY AND ENVIRONMENT:

Health, Safety and Protection of the Environment are the priority areas for the Company. The Company continues to put special emphasis in this area at every stage, from conception and design of new products, optimization of process, to commercial manufacturing and delivery of goods to the customers. Recently company has successfully completed DNV-GL Periodic Recertification Audit of ISO 14001:2018 & OHSAS ISO 45001:2018.

a) Health:

A special committee ensures good sanitation and hygienic condition in the plant and canteen. Medical examination of all the employees is carried out annually. Six monthly medical examinations are conducted for the employees who are working in hazardous areas. Health awareness trainings and programs are being conducted regularly. Updating of our occupational health centre is being carried out.

b) Safety:

Internal and External Safety Audit, regular inspections pertaining to risks and hazards for Ethoxylation/ Propoxylation process are carried out as per the provisions of Factories Act. DCS system has been installed for Ethoxylation/ Propoxylation process to ensure enhanced safety features and automation to nullify human errors. HAZOP Study and Risk Assessment are carried out to identify the potential hazards as proactive measures to enhance safety. Appropriate corrective actions are implemented.

PPD Phase 2 project installation was completed in timely manner. Regular inspections risks and hazards for Esterification/ Polymerization process are carried out as per the provisions of Factories Act. Indicative PLC system has been installed for Esterification/ Polymerization process to ensure enhanced safety features to reduce human errors. HAZOP Study and Risk Assessment are carried out to identify the potential hazards as proactive measures to enhance safety. Appropriate corrective actions are implemented.

Un-planned Mock drills are conducted to ensure the Emergency preparedness as per the requirement of The Factories Act, 1948 & planned Mock drills are conducted to train the employees.

Every year Safety week is celebrated from 4th March to 10th March during which competitions, lectures and training sessions are organized to inculcate and enforce the need for a safe working environment and Emergency Planning. Ensure safe & healthy work environment within worksite by safe work practice. Provide safe & healthy working environment to all for Prevention of injury & ill health.

Engage People on worksite in Environment, Health and Safety related matters through effective participation & consultation. Elaborate firefighting system comprising of alarm systems, manual call points, sprinkler systems, pressurized fire hydrant system to handle emergencies. c) Environment:

Regular environment monitoring is carried out to ensure pollution levels for air and water are below the specified limits by the State Pollution Control Board. Strict adherence to environment rules is ensured by conducting inspections and environment audit.

Separate environment cell equipped monitoring laboratory facility operate to carry environment monitoring function. Complied with all legal & other compliance obligations concerning environment, health safety. Our commitment to manufacturing of products in a safe and environmentally conscious manner is paramount.

Effluent Treatment Plant is equipped with SUF (submersible ultra-filtration) technology and treated effluent is used in various processes, thus, increasing water conservation. Vacuum pumps have been operated in closed loop circulation to minimize the water consumption. This has resulted in reduction of 2100 KL/month.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO:

The particulars relating to conservation of energy, technology absorption, foreign exchange earnings and outgo for F.Y. ended March 31, 2023, as required to be disclosed under the Act, is annexed as

‘Annexure III' LOANS, GUARANTEES OR INVESTMENTS UNDER SECTION 186 OF THE COMPANIES ACT, 2013:

The Company has not provided any loan or given any guarantee / security to any person.

Details of investment made by the Company are provided in the financial statements, under Investment Schedule.

DEPOSITS:

The Company has not accepted any deposits covered under Chapter V of the Companies Act, 2013, during the financial year ended March 31, 2023.

RELATED PARTIES TRANSACTIONS:

All Related Party Transactions that were entered into during the financial year ended March 31, 2023, were on an arm's length basis, in the ordinary course of business and were in compliance with the applicable provisions of Companies Act, 2013 and the SEBI (Listing Obligations and Disclosures Requirement) Regulation 2015 ("Listing Regulations"). As per the Regulation 23(4) of the Listing Regulations, the Company sought approval of shareholders in the 62nd Annual General Meeting, by passing necessary resolution for material related party transaction to be entered from the conclusion of the 62nd Annual General Meeting (AGM) upto the date of the 63rd AGM.

The approval of members is being sought for Material Related Party Transactions for Sale of Goods to ChampionX Dai-ichi India Private Limited at the ensuing AGM.

All the Related Party Transactions are placed before the Audit Committee for approval. Prior omnibus approval of the Audit Committee is obtained for the transactions which are repetitive in nature. A statement of all Related Party Transactions is placed before the Audit Committee for its review on a quarterly basis, specifying the nature, value and terms and conditions of the transactions.

Details of Related Party Transaction Policy are provided in Corporate Governance Report.

ANNUAL RETURN:

As required under Section 92(3) of the Companies Act, 2013, the Annual Return is hosted on the website of the Company at http://www.dai-ichiindia.com/wp-content/uploads/2023/02/Draft-Annual-Return_FY-2022-23.pdf

CORPORATE GOVERNANCE:

In accordance with provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations'), a detailed report on Corporate Governance is included in the Annual Report. M/s. Vinod Kothari & Company, Practicing Company Secretaries, who are also the "Secretarial Auditors" of your Company, have certified that your Company is in compliance with the requirements of Corporate Governance in terms of Listing Regulations and their Compliance Certificate is annexed to the Report on Corporate Governance.

RISK MANAGEMENT POLICY:

The Company has in place a Risk Management Policy which identifies elements of risk and the measures to counter it. The policy is reviewed by the Board every year, at the first Board Meeting held after the commencement of the financial year.

VIGIL MECHANISM/ WHISTLE BLOWER POLICY:

The Vigil Mechanism as envisaged in the Companies Act, 2013, the rules prescribed thereunder and the SEBI Listing Regulations is implemented through the Vigil Mechanism/ Whistle Blower Policy of the Company to enable the Directors and employees to report genuine concerns, to provide for adequate safeguards against victimisation of persons who use such mechanism and make provision for direct access to the Chairman of the Audit Committee.

Vigil Mechanism/ Whistle Blower Policy of the Company is available on the Company's website and can be accessed at website of Company at www.dai-ichiindia.com

DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:

The Company has in place a Prevention of Sexual Harassment Policy in line with the requirements of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. An Internal Committee has been set up to redress complaints received regarding sexual harassment. All employees (permanent, contractual, temporary, trainees) are covered under this policy.

During the financial year 2022-23, there were no complaints with allegations of any sexual harassment received or reported.

CREDIT RATING:

The Company's Banking loan facilities are rated by CRISIL Rating Limited (CRISIL). The ratings given by CRISIL for Short term borrowings and long-term borrowings of the Company are CRISIL A4+ and CRISIL BB/Stable respectively. There was no revision in the said ratings during the financial year under review.

UNPAID AND UNCLAIMED DIVIDEND AMOUNTS TO IEPF:

The unclaimed and unpaid interim dividend amount declared for the Financial Year 2015-16 was due to be transferred to the Investor Education and Protection Fund (IEPF) on March 16, 2023, in accordance with the provisions of Section 124 of the Companies Act, 2013 on completion of 7 (Seven) years from the date of its declaration. The Company accordingly transferred the unclaimed interim dividend for the Financial Year 2015-16 to IEPF.

TRANSFER OF EQUITY SHARES TO INVESTOR EDUCATION AND PROTECTION FUND (IEPF) ACCOUNT:

The Company had sent reminders to those shareholders who have not claimed their dividend for consecutive period of 7 financial years, at their registered addresses and newspaper advertisement was published for claiming such unclaimed and unpaid dividends. The Company accordingly transferred such shares to Investor Education and Protection Fund (IEPF), who have not claimed the dividend for consecutive period of 7 years since Interim dividend declared for the financial year 2015-16. The details of which are also uploaded on the website of the company at www.dai-ichiindia.com.

The Company is in compliance with the aforesaid provisions and the IEPF Rules.

SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS/COURTS/TRIBUNALS:

During the financial year under review, there are no significant and material orders passed by the regulators or courts or tribunals which impact the Company's going concern status and its operations in the future.

PROCEEDINGS UNDER INSOLVENCY & BANKRUPTCY CODE:

No application has been made under the Insolvency and Bankruptcy Code; hence the requirement to disclose the details of application made or any proceeding pending under the Insolvency and Bankruptcy Code, 2016 (31 of 2016) during the year alongwith their status as at the end of the financial year is not applicable.

ONE-TIME SETTLEMENT:

The requirement to disclose the details of difference between amount of the valuation done at the time of one-time settlement and the valuation done while taking loan from the Banks or Financial Institutions along with the reasons thereof, is not applicable.

COMPLIANCE WITH SECRETARIAL STANDARDS:

During the financial year under review, the Company has complied with the applicable Secretarial Standards as amended and issued by Institute of Company Secretaries of India and notified by the Ministry of Corporate Affairs of India.

LISTING:

The Equity Shares of your company are presently listed on BSE Limited and the Company has paid the annual listing fees for the financial year 2023-24.

ACKNOWLEDGEMENT:

Your Directors wish to place on record their appreciation of the contribution made by the employees of the Company. The Directors wish to convey their appreciation to the Banks, dealers and other business associates and the shareholders for their continuous trust and support.

CAUTIONARY NOTE:

Certain statements in the Directors' Report and Management & Discussion Analysis section may be forward looking and are stated as required by applicable laws and regulations. Many factors may affect the actual results, which could be different from what the Directors envisage in terms of future performance and outlook.

For and on behalf of the Board
Place : Mumbai Mrs. Shernaz Vakil Ms. Meher Vakil
Date : May 30, 2023 Chairperson & Whole-time Director Managing Director

   

Dai-ichi Karkaria Ltd Company Background

S F VakilMeher Vakil
Incorporation Year1960
Registered OfficeLiberty Cinema Building,Sir Vithaldas Thackersey Marg
Mumbai,Maharashtra-400020
Telephone91-022-22017130/22015895,Managing Director
Fax91-022-22096976
Company SecretaryAnkit Shah
AuditorBSR & Co LLP
Face Value10
Market Lot1
ListingBSE,
RegistrarSharex Dynamic (India) Pvt Ltd
C-101 247 Park ,L B S Marg ,Vikhroli West ,Mumbai - 400083

Dai-ichi Karkaria Ltd Company Management

Director NameDirector DesignationYear
S F VakilChairperson & Whole Time Direc2023
A H JehangirNon Executive Director2023
K D PatelIndependent Director2023
K M ElaviaIndependent Director2023
Meher VakilManaging Director2023
Ashok V HiremathIndependent Director2023
Ankit ShahCompany Sec. & Compli. Officer2023
CYRUS ADI BAGWADIAIndependent Director2023
BEHRAM MANECK SORABJIIndependent Director2023

Dai-ichi Karkaria Ltd Listing Information

Dai-ichi Karkaria Ltd Finished Product

Product NameUnit Installed
Capacity
Production
Quantity
Sales
Quantity
Sales
Value
Sale of ProductsNA000106.13
Other Operating RevenueNA0000.92
ServicesNA0000.12
Oil FieldNA0000
OthersNA0000
Others TradedTon0000
TextileNA0000
Bulk DrugsTon0000
Anionic/CationicNA0000
Non IonicNA0000
Speciality ChemicalsTon0000
FormulationsNo0000
FlocculantsNA0000

Contact us Contact us